Click here to download

Entry and submarket concentration: empirical evidence from the pharmaceutical industry
Author/s: Maria Letizia Giorgetti 
Year:  2012 Issue: Language: English 
Pages:  25 Pg. 5-29 FullText PDF:  197 KB
DOI:  10.3280/POLI2012-003001
(DOI is like a bar code for intellectual property: to have more infomation:  clicca qui   and here 

The paper investigates the decisions of companies to enter new submarkets, analyzing the relationship between submarket concentration and entry through the explanatory power of submarkets. The relationship is analyzed both at the aggregate level for all countries and both at the country-specific level using a pharmaceutical company dataset gathered in seven countries in the 1987-1998 period. A Bayesian panel probit model enables us to measure entry into a new submarket using the lagged dependent variable to incorporate potential state persistence. The results obtained at the submarket level indicate a negative correlation between concentration and entry by diversification, although previous literature at market level has indicated conflicting results for the same relationship.
Keywords: Entry, diversification, Bayesian inference, panel data, probit model, random effects
Jel Code: L11, L65, C11, C23, C25

Maria Letizia Giorgetti, in "ECONOMIA E POLITICA INDUSTRIALE " 3/2012, pp. 5-29, DOI:10.3280/POLI2012-003001


FrancoAngeli is a member of Publishers International Linking Association a not for profit orgasnization wich runs the CrossRef service, enabing links to and from online scholarly content